BMO Capital analyst Michael Zaremski initiated coverage of Travelers with an Outperform rating and $212 price target, calling it his top pick among the commercial insurers. His EPS estimates "materially" exceed consensus given his view that Travelers’ reserving and cost of goods sold position continues to improve, the analyst tells investors.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TRV:
